| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Arrowhead Pharmaceuticals, Inc. (ARWR) has 12 insiders with recent SEC Form 4 filings, including 2 buys and 18 sells. ARWR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.79M | $311.00M | - | |
| COO | 473.3K | $38.81M | - | |
| Other | 227.0K | $18.61M | - | |
| CFO | 162.9K | $13.36M | - | |
| Dir | 123.1K | $10.09M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 17, 2020 | Given Douglas B66 | Director | Sell | 9,575 | $79.32 | $759,442.50 | -6.9% | |
| Dec 10, 2020 | Waddill William D.50 | Director | Sell | 3,000 | $71.26 | $213,780.00 | -5.5% | |
| Dec 9, 2020 | Anzalone Christopher Richard60 | Chief Executive Officer | Sale+OE | 55,000 | $68.73 | $3,780,347.33 | -0.4% | |
| Nov 20, 2020 | Bradshaw Curt | Chief Scientific Officer | Sell | 31,250 | $69.06 | $2,158,125.00 | -66.7% | |
| Nov 19, 2020 | San Martin Javier65 | Chief Medical Officer | Sell | 19,500 | $69.39 | $1,353,105.00 | -13.0% | |
| Nov 9, 2020 | Myszkowski Kenneth Allen68 | Chief Financial Officer | Sale+OE | 43,505 | $69.37 | $3,018,070.50 | -4.7% | |
| Oct 23, 2020 | Anzalone Christopher Richard60 | Chief Executive Officer | Sell | 100,000 | $58.21 | $5,821,031.52 | -2.0% | |
| Oct 20, 2020 | Myszkowski Kenneth Allen68 | Chief Financial Officer | Sale+OE | 29,166 | $54.04 | $1,576,130.64 | -6.4% | |
| Oct 9, 2020 | Ferrari Mauro71 | Director | Sell | 10,000 | $48.00 | $480,000.00 | -24.4% | |
| Oct 8, 2020 | De Backer Marianne65 | Director | Buy | 1,000 | $50.47 | $50,465.00 | +3.0% |